Sex-dependent lifespan extension of Apc Min/+ FAP mice by chronic mTOR inhibition.

Background Apc Min/+ mice model familial adenomatous polyposis (FAP), a disease that causes numerous colon polyps leading to colorectal cancer. We previously showed that chronic treatment of Apc Min/+ females with the anti-aging drug, rapamycin, restored a normal lifespan through reduced polyposis and anemia prevention. Lifespan extension by chronic rapamycin in wildtype UM-HET3 mice is sex-dependent with females gaining the most benefit. Whether Apc Min/+ mice have a similar sex-dependent response to chronic mTOR inhibition is not known. Methods To address this knowledge gap and gain deeper insight into how chronic mTOR inhibition prevents intestinal polyposis, we compared male and female Apc Min/+ mice responses to chronic treatment with a rapamycin-containing diet. Animals were fed a diet containing either 42 ppm microencapsulate rapamycin or empty capsules, one group was used to determine lifespan and a second group with similar treatment was harvested at 16 weeks of age for cross-sectional studies. Results We found that the survival of males is greater than females in this setting (P < 0.0197). To explore the potential basis for this difference we analyzed factors affected by chronic rapamycin. Immunoblot assays showed that males and females exhibited approximately the same level of mTORC1 inhibition using phosphorylation of ribosomal protein S6 (rpS6) as an indirect measure. Immunohistochemistry assays of rpS6 phosphorylation showed that rapamycin reduction of mTORC1 activity was on the same level, with the most prominent difference being in intestinal crypt Paneth cells in both sexes. Chronic rapamycin also reduced crypt depths in both male and female Apc Min/+ mice (P < 0.0001), consistent with reduced crypt epithelial cell proliferation. Finally, chronic rapamycin prevented anemia equally in males and females. Conclusions In males and females, these findings link rapamycin-mediated intestinal polyposis prevention with mTORC1 inhibition in Paneth cells and concomitant reduced epithelial cell proliferation.

[1]  P. Hasty,et al.  Rapamycin Extends Life Span in ApcMin/+ Colon Cancer FAP Model. , 2020, Clinical colorectal cancer.

[2]  A. van Oudenaarden,et al.  Enteroendocrine and tuft cells support Lgr5 stem cells on Paneth cell depletion , 2019, Proceedings of the National Academy of Sciences.

[3]  P. Khaitovich,et al.  Identification and Application of Gene Expression Signatures Associated with Lifespan Extension. , 2019, Cell metabolism.

[4]  H. Clevers,et al.  Paneth Cells Respond to Inflammation and Contribute to Tissue Regeneration by Acquiring Stem-like Features through SCF/c-Kit Signaling. , 2018, Cell reports.

[5]  R. Kondratov,et al.  Caloric restriction effects on liver mTOR signaling are time-of-day dependent , 2018, Aging.

[6]  Min Huang,et al.  Aspirin disrupts the mTOR-Raptor complex and potentiates the anti-cancer activities of sorafenib via mTORC1 inhibition. , 2017, Cancer letters.

[7]  Carson C. Thoreen.  The molecular basis of mTORC1-regulated translation. , 2017, Biochemical Society transactions.

[8]  Andrew H. Beck,et al.  Aspirin Suppresses Growth in PI3K-Mutant Breast Cancer by Activating AMPK and Inhibiting mTORC1 Signaling. , 2017, Cancer research.

[9]  P. Scheet,et al.  Genomic Landscape of Colorectal Mucosa and Adenomas , 2016, Cancer Prevention Research.

[10]  Alexander van Oudenaarden,et al.  Replacement of Lost Lgr5-Positive Stem Cells through Plasticity of Their Enterocyte-Lineage Daughters. , 2016, Cell stem cell.

[11]  C. Livi,et al.  Adaptations to chronic rapamycin in mice , 2016, Pathobiology of aging & age related diseases.

[12]  Michael N. Hall,et al.  mTORC1 mediated translational elongation limits intestinal tumour initiation and growth , 2014, Nature.

[13]  Robert S. DiPaola,et al.  Repurposing of Metformin and Aspirin by Targeting AMPK-mTOR and Inflammation for Pancreatic Cancer Prevention and Treatment , 2014, Cancer Prevention Research.

[14]  Z. D. Sharp,et al.  Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction , 2014, Aging cell.

[15]  C. Livi,et al.  eRapa Restores a Normal Life Span in a FAP Mouse Model , 2013, Cancer Prevention Research.

[16]  C. Livi,et al.  Rapamycin extends life span of Rb1+/− mice by inhibiting neuroendocrine tumors , 2013, Aging.

[17]  R. Fodde,et al.  Paneth Cells in Intestinal Homeostasis and Tissue Injury , 2012, PloS one.

[18]  Dudley Lamming,et al.  mTORC1 in the Paneth cell niche couples intestinal stem cell function to calorie intake , 2012, Nature.

[19]  Hans Clevers,et al.  Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts , 2011, Nature.

[20]  K. Flurkey,et al.  Life extension by diet restriction and N-acetyl-L-cysteine in genetically heterogeneous mice. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[21]  H. Brenner,et al.  Protection from colorectal cancer after colonoscopy: Population-based case-control study , 2010 .

[22]  Marco Pahor,et al.  Rapamycin fed late in life extends lifespan in genetically heterogeneous mice , 2009, Nature.

[23]  M. Bulyk,et al.  Short-Term Calorie Restriction in Male Mice Feminizes Gene Expression and Alters Key Regulators of Conserved Aging Regulatory Pathways , 2009, PloS one.

[24]  Hans Clevers,et al.  Crypt stem cells as the cells-of-origin of intestinal cancer , 2009, Nature.

[25]  Kenneth L. Hensley,et al.  Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice , 2008, Aging cell.

[26]  H. Lane,et al.  Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcΔ716 mice , 2008, Proceedings of the National Academy of Sciences.

[27]  H. Clevers,et al.  Identification of stem cells in small intestine and colon by marker gene Lgr5 , 2007, Nature.

[28]  L. Rönnstrand.  Signal transduction via the stem cell factor receptor/c-Kit , 2004, Cellular and Molecular Life Sciences CMLS.

[29]  I. Christensen,et al.  Duodenal adenomatosis in familial adenomatous polyposis , 2004, Gut.

[30]  R. Lin,et al.  Rapamycin-insensitive Regulation of 4E-BP1 in Regenerating Rat Liver* , 2001, The Journal of Biological Chemistry.

[31]  M. Wallace,et al.  Upper gastrointestinal disease in patients with familial adenomatous polyposis , 1998, The British journal of surgery.

[32]  S. Altschul,et al.  Identification of FAP locus genes from chromosome 5q21. , 1991, Science.

[33]  K. Kinzler,et al.  Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. , 1991, Science.

[34]  H. Pitot,et al.  A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. , 1990, Science.

[35]  S. Winawer,et al.  Risk and surveillance of individuals with heritable factors for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer. , 1990, Bulletin of the World Health Organization.